Abstract
Introduction: Cell death markers, caspase-cleaved [CK-18 (M30)] and total cytokeratin [CK-18 (M65)] indicate the extent and relative proportions of apoptotic and necrotic cell death in acute liver failure (ALF) patients. Serum levels of apoptotic biomarkers [CK 18 (M30 and M 65)] are expected to be elevated in ALF compared to controls and these biomarkers may be linked to outcome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
